Bcl-2-IN-6
Bcl-2-IN-6 (compound 10) is a potent Bcl-2 (B-cell lymphoma-2) inhibitor. Bcl-2-IN-7 down-regulates the expression of Bcl-2, and increases the expression of p53, Bax, and caspase-7 mRNA. Bcl-2-IN-7 induces cell cycle arrest and apoptosis in breast cancer MCF-7 cells. Bcl-2-IN-7 shows good anticancer activity, with IC50 values of 20.91, 22.30, 42.29, and 48.00 μM against MCF-7, LoVo, HepG2, and A549 cell lines, respectively[1].
Product Specifications
CAS Number
3027734-50-2
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; Caspase; MDM-2/p53
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl-2-in-6.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC=CC(CC)=C1)CSC(N2C3=CC=C(S(=O)(N)=O)C=C3)=NC4=C(C=CC=C4OC)C2=O
Molecular Formula
C25H24N4O5S2
Molecular Weight
524.61
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bax; Bcl-2; Caspase 7
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
FEN1, ID (Flap Endonuclease 1, Flap Structure-specific Endonuclease 1, Maturation Factor 1, MF1, DNase IV, hFEN-1, RAD2) (MaxLight 490)
FEN1, ID (Flap Endonuclease 1, Flap Structure-specific Endonuclease 1, Maturation Factor 1, MF1, DNase IV, hFEN-1, RAD2) (MaxLight 490)
OVOL1, NT (OVOL1, Putative transcription factor Ovo-like 1)
OVOL1, NT (OVOL1, Putative transcription factor Ovo-like 1)
